MX2016010967A - Nuevas composiciones para tratar lesiones neuronales mecanicas. - Google Patents

Nuevas composiciones para tratar lesiones neuronales mecanicas.

Info

Publication number
MX2016010967A
MX2016010967A MX2016010967A MX2016010967A MX2016010967A MX 2016010967 A MX2016010967 A MX 2016010967A MX 2016010967 A MX2016010967 A MX 2016010967A MX 2016010967 A MX2016010967 A MX 2016010967A MX 2016010967 A MX2016010967 A MX 2016010967A
Authority
MX
Mexico
Prior art keywords
new compositions
neuronal injuries
mechanical neuronal
treating mechanical
treating
Prior art date
Application number
MX2016010967A
Other languages
English (en)
Inventor
Cohen Daniel
Chumakov Ilya
Nabirochkin Serguei
Original Assignee
Pharnext
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/187,841 external-priority patent/US9393241B2/en
Application filed by Pharnext filed Critical Pharnext
Publication of MX2016010967A publication Critical patent/MX2016010967A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

La presente invención se refiere a composiciones y a procedimientos para el tratamiento de las lesiones neuronales mecánicas.
MX2016010967A 2014-02-24 2015-02-23 Nuevas composiciones para tratar lesiones neuronales mecanicas. MX2016010967A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/187,841 US9393241B2 (en) 2009-06-02 2014-02-24 Compositions for treating CMT and related disorders
PCT/EP2015/053700 WO2015124763A1 (en) 2014-02-24 2015-02-23 New compositions for treating mechanical neuronal injuries

Publications (1)

Publication Number Publication Date
MX2016010967A true MX2016010967A (es) 2016-11-29

Family

ID=52669585

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016010967A MX2016010967A (es) 2014-02-24 2015-02-23 Nuevas composiciones para tratar lesiones neuronales mecanicas.

Country Status (14)

Country Link
EP (1) EP3110411B1 (es)
JP (1) JP6522641B2 (es)
KR (1) KR20160126045A (es)
CN (1) CN106456571B (es)
AU (1) AU2015220717B2 (es)
BR (1) BR112016019395A2 (es)
CA (1) CA2940442C (es)
EA (1) EA201691703A1 (es)
ES (1) ES2774373T3 (es)
IL (1) IL246919B (es)
MX (1) MX2016010967A (es)
SG (1) SG11201606485VA (es)
UA (1) UA118785C2 (es)
WO (1) WO2015124763A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018076060A1 (en) * 2016-10-26 2018-05-03 Genea Ip Holdings Pty Ltd Improved generation of muscle lineage cells and therapeutic uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099947A1 (en) * 2005-11-03 2007-05-03 Alkermes, Inc. Methods and compositions for the treatment of brain reward system disorders by combination therapy
US20080255062A1 (en) * 2007-02-13 2008-10-16 University Of Manitoba Axon regeneration from adult sensory neurons
EP2065038A1 (en) * 2007-11-30 2009-06-03 Pharnext New therapeutic approaches for treating Charcot-Marie-Tooth disease
EP2135607A1 (en) * 2008-06-18 2009-12-23 Pharnext Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
EP2263665A1 (en) * 2009-06-02 2010-12-22 Pharnext New compositions for treating CMT and related disorders

Also Published As

Publication number Publication date
WO2015124763A1 (en) 2015-08-27
UA118785C2 (uk) 2019-03-11
IL246919B (en) 2020-04-30
BR112016019395A2 (pt) 2017-10-24
SG11201606485VA (en) 2016-09-29
KR20160126045A (ko) 2016-11-01
AU2015220717B2 (en) 2020-03-26
CN106456571B (zh) 2021-07-27
CN106456571A (zh) 2017-02-22
JP6522641B2 (ja) 2019-05-29
CA2940442C (en) 2022-04-12
EP3110411B1 (en) 2019-11-06
AU2015220717A1 (en) 2016-08-25
CA2940442A1 (en) 2015-08-27
JP2017507941A (ja) 2017-03-23
ES2774373T3 (es) 2020-07-20
IL246919A0 (en) 2016-09-29
EP3110411A1 (en) 2017-01-04
EA201691703A1 (ru) 2017-04-28

Similar Documents

Publication Publication Date Title
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
HK1243640A1 (zh) 用於治療潰瘍的方法和組合物
SG11201700079VA (en) Combination therapy compositions and methods for treating cancers
ZA201707303B (en) Compositions and methods for the treatment of immunodeficiency
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
PL3261726T3 (pl) Kompozycja do leczenia trądziku
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
HK1258696A1 (zh) 治療或預防皮膚障礙的新型組合物和方法
IL262419A (en) A therapeutic composition containing enzyme-rich cannabis
HK1247789A1 (zh) 用於治療水腫的組合物和方法
HK1245127A1 (zh) 治療腦疾病的方法和組合物
MX2017006019A (es) Apilimod para uso en el tratamiento de melanoma.
ZA201902781B (en) Compositions and methods for the treatment of xerostomia
SG11201702554QA (en) Compositions and methods for the treatment of multiple sclerosis
IL249640A0 (en) Preparations for the treatment of nosebleeds
HK1255221A1 (zh) 使用卡多曲組合物進行治療的方法
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
HK1257853A1 (zh) 用於治療和預防放射性皮炎的組合物和方法
TW201613610A (en) Use of ginsenoside M1 for treating lupus nephritis
IL251736B (en) Methods and compositions for the treatment of radiation-related disorders
MX2021008225A (es) Composiciones y metodos para tratamiento de crecimiento celular anormal.
GB201621737D0 (en) Compositions and methods of treatment
HK1244782A1 (zh) 用於治療疾病和病癥的組合物和方法
DK3313207T3 (en) Compositions and methods for the treatment of malnutrition

Legal Events

Date Code Title Description
FG Grant or registration